Life Sciences

The project will involve other site improvements, including the construction of outdoor patios, landscape improvements. A portion of Research Drive will be relocated to segregate pedestrian and truck traffic.

After months of negotiations, including those with an anonymous, unsolicited third party, Marlborough-based biotech firm Akoya Biosciences has officially been acquired by Quanterix.

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.

The firm is expanding its facility in Devens after designating the site as the company’s headquarters in March.

Three Central Massachusetts companies have been named among the best public companies to work for by the U.S. News & World Report.

Three Central Massachusetts companies have split more than $2 million in tax incentives as part of a broader state initiative to create new life sciences industry jobs across the commonwealth. 

Startups have navigated the perilous Valley of Death period with varying levels of success. Conifer Life Sciences Group at MBI is trying to change that.

Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer . 

Two months after its CFO abruptly resigned, Arch Therapeutics, a Framingham-based biotechnology company, has filed for Chapter 11 bankruptcy.